Julia Martinez-Sanchez, Roger Pascual-Diaz, Marta Palomo, Ana Belén Moreno-Castaño, Helena Ventosa, María Queralt Salas, Montserrat Rovira, Gines Escolar, Enric Carreras, Maribel Diaz-Ricart
Post-transplantation cyclophosphamide (PTCy) has decreased GVHD incidence. Endothelial damage in allo-HCT is caused by multiple factors, including conditioning treatments and some immunosupressants, and underlies HCT-complications as GVHD. Nevertheless, the specific impact of PTCy on the endothelium remains unclear. We evaluated the effect of mafosfamide (MAF), an active Cy analog, on endothelial cells (ECs) vs. cyclosporine A (CSA), with known damaging endothelial effect. ECs were exposed to MAF and CSA to explore changes in endothelial damage markers: (i) surface VCAM-1, (ii) leukocyte adhesion on ECs, (iii) VE-cadherin expression, (iv) production of VWF, and (v) activation of intracellular signaling proteins (p38MAPK, Akt)...
January 13, 2023: Bone Marrow Transplantation